JANELLA DEWITT: Open Payments
NPI 1295820983 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,920 in 171 payments from 28 companies in 2025. Trend: 2023 $4,007 · 2024 $3,821 · 2025 $3,920
Food & beverage: $3,920
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $424 |
| GlaxoSmithKline, LLC. | 23 | $381 |
| GENZYME CORPORATION | 11 | $324 |
| Pharming Healthcare, Inc. | 8 | $288 |
| Amgen Inc. | 9 | $282 |
| Genentech USA, Inc. | 11 | $260 |
| PFIZER INC. | 18 | $247 |
| Novartis Pharmaceuticals Corporation | 13 | $229 |
| Regeneron Healthcare Solutions, Inc. | 12 | $201 |
| CSL Behring | 11 | $191 |
Products named: DUPIXENT, TEZSPIRE, Xolair, RUCONEST, NUCALA, FASENRA, TRELEGY ELLIPTA, Rhapsido.
Industry payments across KS — which companies pay providers there.
